首页 | 本学科首页   官方微博 | 高级检索  
     


First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
Authors:Ahmet Emre Eskazan  Mesut Ayer  Bulent Kantarcioglu  Deniz Arica  Naciye Demirel  Demet Aydin  Fevzi Firat Yalniz  Tugrul Elverdi  Ayse Salihoglu  Muhlis Cem Ar  Seniz Ongoren Aydin  Zafer Baslar  Yildiz Aydin  Nukhet Tuzuner  Ugur Ozbek  Teoman Soysal
Affiliation:1. Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, , Istanbul, Turkey;2. Department of Haematology, Haseki Training and Research Hospital, , Istanbul, Turkey;3. Department of Haematology, Okmeydani Training and Research Hospital, , Istanbul, Turkey;4. Department of Pathology, Cerrahpasa Faculty of Medicine, Istanbul University, , Istanbul, Turkey;5. Department of Genetics, Institute of Experimental Medicine (DETAE), Istanbul University, , Istanbul, Turkey
Abstract:
Keywords:chronic myeloid leukaemia  efficacy  generic  imatinib mesylate
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号